Frances L. Johnson
Corporate Officer/Principal presso PERSPECTIVE THERAPEUTICS, INC.
Provenienza dei contatti di primo grado di Frances L. Johnson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Medical Specialties | 9 | |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Frances L. Johnson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member | |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Investment Banks/Brokers | Corporate Officer/Principal | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Viewpoint (US) | Director/Board Member Director/Board Member | ||
| CUE BIOPHARMA, INC. | Biotechnology | Chairman Chief Executive Officer | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
Freedom Innovations LLC
 Freedom Innovations LLC Medical SpecialtiesHealth Technology Freedom Innovations LLC designs, manufactures, and markets prosthetic devices. The firm focuses on developing lower limb prosthetic solutions in collaboration with prosthetists and amputees. Its products include Renegade, Thrive, Pacifica, DynAdapt, Agilix, and Maverick Comfort AT. The company was founded in 2002 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
Telegraph Hill Partners Management Co. LLC
 Telegraph Hill Partners Management Co. LLC Investment ManagersFinance Telegraph Hill Partners Management Co. LLC (Telegraph Hill Partners) is a venture capital firm founded in 2001 by Robert G. Shepler, Thomas A. Raffin and Deval A. Lashkari. The firm is headquartered in San Francisco, California. | Investment Managers | Founder | |
| LDR HOLDING CORP | Medical Specialties | Director/Board Member | |
Miles, Inc.
 Miles, Inc. Chemicals: Major DiversifiedProcess Industries Part of Bayer AG, Miles, Inc. is a chemical company. The company is based in Pittsburgh, PA. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| MORPHOSYS AG | Biotechnology | Director/Board Member | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Chief Executive Officer | |
| Philipps University of Marburg | College/University | Doctorate Degree | |
| Columbia Business School | College/University | Masters Business Admin | |
KBP Biosciences USA, Inc.
 KBP Biosciences USA, Inc. Miscellaneous Commercial ServicesCommercial Services KBP Biosciences engages in conducting biotechnological research to develop therapies for patients. The company was founded by Huang Zhenhua in and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Chief Executive Officer | |
The Magstim Co. Ltd.
 The Magstim Co. Ltd. Medical SpecialtiesHealth Technology The Magstim Co. Ltd. researches, develops, manufactures, and markets medical and research devices in the neurological and surgical fields. It offers instructions and commission, software upgrades, and repair services. The company was founded in 1990 and is headquartered in Whitland, the United Kingdom. | Medical Specialties | Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
| National Institute of Health Policy | Corporate Officer/Principal | ||
| University of Iowa | College/University | Corporate Officer/Principal | |
KPMG Advisory SP ZOO Spolka Komandytowa
 KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Investment Managers | Corporate Officer/Principal | |
| Santa Clara University | College/University | Undergraduate Degree | |
| Alcedo Capital, Inc. | Founder | ||
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Biotechnology | Founder | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
ICAP Patent Brokerage LLC
 ICAP Patent Brokerage LLC Real Estate DevelopmentFinance ICAP Patent Brokerage LLC provides intellectual property brokerage, live patent auction, and sealed-bid patent auction services. It operates a live auctioning platform for the buyers and sellers of patents and other intellectual property assets. The company is headquartered in New York, NY. | Real Estate Development | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 33 |
| Germania | 7 |
| Francia | 3 |
| Danimarca | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 27 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 4 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 69 |
| Corporate Officer/Principal | 30 |
| Chief Executive Officer | 24 |
| Director of Finance/CFO | 22 |
| Independent Dir/Board Member | 15 |
Contatti più connessi
| Insiders | |
|---|---|
| Robert Williamson | 25 |
| Frank Morich | 21 |
| Heidi Henson | 20 |
| Thomas Raffin | 19 |
| Johan Spoor | 18 |
| Lori Woods | 13 |
| Cameron Gray | 11 |
| Charles Link | 10 |
| Jonathan Hunt | 8 |
| Markus Puhlmann | 5 |
| Mark Austin | 4 |
| Michael K. Schultz | 4 |
| Curtis R. Nelson | 2 |
| Heyward H. Coleman | 1 |
| Andrew Bright | 1 |
- Borsa valori
- Insiders
- Frances L. Johnson
- Connessioni Società
